Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Apyx Medical (APYX) Shares Outstanding (Diluted Average) (2016 - 2023)

Historic Shares Outstanding (Diluted Average) for Apyx Medical (APYX) over the last 14 years, with Q4 2023 value amounting to $34.6 million.

  • Apyx Medical's Shares Outstanding (Diluted Average) rose 30.71% to $34.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $34.6 million, marking a year-over-year increase of 30.71%. This contributed to the annual value of $34.6 million for FY2023, which is 30.71% up from last year.
  • Per Apyx Medical's latest filing, its Shares Outstanding (Diluted Average) stood at $34.6 million for Q4 2023, which was up 30.71% from $34.5 million recorded in Q4 2022.
  • Apyx Medical's 5-year Shares Outstanding (Diluted Average) high stood at $34.6 million for Q4 2023, and its period low was $34.1 million during Q4 2019.
  • For the 5-year period, Apyx Medical's Shares Outstanding (Diluted Average) averaged around $34.4 million, with its median value being $34.3 million (2021).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first crashed by 86.42% in 2019, then surged by 53.59% in 2022.
  • Quarter analysis of 5 years shows Apyx Medical's Shares Outstanding (Diluted Average) stood at $34.1 million in 2019, then increased by 0.42% to $34.2 million in 2020, then increased by 0.35% to $34.3 million in 2021, then increased by 0.54% to $34.5 million in 2022, then increased by 0.31% to $34.6 million in 2023.
  • Its Shares Outstanding (Diluted Average) was $34.6 million in Q4 2023, compared to $34.5 million in Q4 2022 and $34.3 million in Q4 2021.